Spark Therapeutics, Inc.

Philadelphia, Florida, United States gene.com

Overview

Spark Therapeutics, Inc. is a leading biotechnology company focused on the development of gene therapy solutions for genetic diseases. As a subsidiary of Roche, Spark aims to transform the future of genetic medicine through innovation and cutting-edge research.

Therapeutic areas

Genetic DiseasesOphthalmologyHematologyGene Therapy

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Spark Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Apellis Pharmaceuticals, Inc.
United States
Shire Pharmaceuticals
United States
Bayer Healthcare Manufacturing
Germany
Oxford Biomedica plc
United Kingdom
Swedish Orphan Biovitrum AB
Sweden
uniQure Biopharma B.V.
Netherlands
Acceleron Pharma Inc.
United States
Acerta Pharma LLC
USA

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo